[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,961,054
  • Shares Outstanding, K 45,479
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 34 M
  • EBITDA $ 123 M
  • 60-Month Beta 0.96
  • Price/Sales 1.68
  • Price/Cash Flow 15.61
  • Price/Book 1.56

Options Overview Details

View History
  • Implied Volatility 47.44% (+0.38%)
  • Historical Volatility 63.50%
  • IV Percentile 17%
  • IV Rank 22.70%
  • IV High 83.54% on 03/27/26
  • IV Low 36.84% on 09/02/25
  • Expected Move (DTE 33) 1.50 (3.49%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 18
  • Volume Avg (30-Day) 78
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 1,854
  • Open Int (30-Day) 1,489
  • Expected Range 41.62 to 44.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.31
  • Number of Estimates 2
  • High Estimate $0.31
  • Low Estimate $0.30
  • Prior Year $0.24
  • Growth Rate Est. (year over year) +29.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.50 +21.46%
on 04/24/26
46.89 -8.04%
on 04/28/26
+5.59 (+14.89%)
since 04/15/26
3-Month
31.75 +35.81%
on 03/31/26
46.89 -8.04%
on 04/28/26
+6.62 (+18.14%)
since 02/13/26
52-Week
26.84 +60.63%
on 07/18/25
55.00 -21.60%
on 01/13/26
+15.04 (+53.56%)
since 05/15/25

Most Recent Stories

More News
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

OMCL : 43.12 (-1.55%)
3 Stocks Under $50 with Warning Signs

3 Stocks Under $50 with Warning Signs

OMCL : 43.12 (-1.55%)
LKQ : 24.61 (-5.38%)
KSS : 11.77 (-1.34%)
3 Cash-Producing Stocks We Keep Off Our Radar

3 Cash-Producing Stocks We Keep Off Our Radar

LAUR : 32.12 (-1.14%)
OMCL : 43.12 (-1.55%)
CMI : 696.53 (-2.78%)
The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call

OMCL : 43.12 (-1.55%)
Omnicell to Present at the BofA Securities 2026 Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference...

OMCL : 43.12 (-1.55%)
1 Small-Cap Stock to Keep an Eye On and 2 We Ignore

1 Small-Cap Stock to Keep an Eye On and 2 We Ignore

OFG : 43.97 (-0.92%)
OMCL : 43.12 (-1.55%)
VTS : 18.50 (+1.59%)
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer

Newly established role strengthens understanding of healthcare clinician needs to help shape the Company’s innovation priorities and portfolio decisions

OMCL : 43.12 (-1.55%)
OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround

OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround

OMCL : 43.12 (-1.55%)
Omnicell’s (NASDAQ:OMCL) Q1 CY2026: Beats On Revenue

Omnicell’s (NASDAQ:OMCL) Q1 CY2026: Beats On Revenue

OMCL : 43.12 (-1.55%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 43.12 (-1.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 45.56
2nd Resistance Point 44.87
1st Resistance Point 44.00
Last Price 43.12
1st Support Level 42.44
2nd Support Level 41.75
3rd Support Level 40.88

See More

52-Week High 55.00
Fibonacci 61.8% 44.24
Last Price 43.12
Fibonacci 50% 40.92
Fibonacci 38.2% 37.60
52-Week Low 26.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.